The Risk of Recurrent Anaphylaxis

Andrew O'Keefe1, Ann Clarke2, Yvan St Pierre3

  • 1Discipline of Pediatrics, Faculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada.

The Journal of Pediatrics
|October 17, 2016
PubMed

Insights

The yearly recurrence rate of anaphylaxis in children is 17.6%. Factors like asthma and food triggers increase recurrence risk, highlighting the need for better education on avoidance and epinephrine use.

Area of Science:

  • Pediatric Allergy and Immunology
  • Emergency Medicine
  • Clinical Epidemiology

Background:

  • Anaphylaxis recurrence in children poses significant health risks.
  • Understanding recurrence rates and associated factors is crucial for effective management.
  • Previous studies have not fully elucidated recurrence patterns in medically attended pediatric anaphylaxis.

Purpose of the Study:

  • To determine the annual recurrence rate of anaphylaxis in children treated in emergency departments.
  • To evaluate prehospital and emergency department management of recurrent anaphylaxis.
  • To identify factors associated with recurrent anaphylaxis in pediatric patients.

Main Methods:

  • Prospective cohort study within the Cross-Canada Anaphylaxis Registry.
  • Inclusion of children with medically attended anaphylaxis from 3 emergency departments and emergency medical services.
  • Annual follow-up questionnaires and Cox regression analysis to identify recurrence predictors.

Main Results:

  • A yearly anaphylaxis recurrence rate of 17.6% was observed in children.
  • Food was the trigger in 84.6% of recurrent episodes; epinephrine was used in 66.2% of cases.
  • Asthma, food triggers, and epinephrine use during the initial event increased recurrence odds, while peanut triggers decreased them.

Conclusions:

  • The study identifies a significant yearly recurrence rate of anaphylaxis in children.
  • There is a notable underuse of epinephrine in managing anaphylaxis.
  • Educational initiatives are essential to improve avoidance strategies and promote timely epinephrine administration.
Abstract

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
111
Allergic Reactions02:06

Allergic Reactions

Overview
33.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.1K
Cross-reactivity00:42

Cross-reactivity

Overview
33.7K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
116